Reshaping Risk/Reward in Biotech VC
Executive Summary
As returns from internet start-ups continue to reshape venture capital, the risk/reward ratios for biotech companies become less attractive for VC's. Since the biotechnology industry plays a direct role in improving health care, perhaps what's needed are investment incentives provided by public policy.